News

August 15, 2016

Animal Models for CNS Safety Pharmacology under the Spotlight

The pharmaceutical industry has been working to assess the relevance of rodent central nervous system (CNS) safety pharmacology studies in predicting what happens in first-in-human phase I studies. The findings published in Regulatory Toxicology and Pharmacology have important implications for reducing attrition in the drug development pipeline and in reducing animal use.